SCHEMBL7014122

SCHEMBL7014122

CCc1cn2cccc(OCc3ccccc3)c2c1CC(N)=O

nearest known ligand 0.53

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PLA2G1B P04054 10/20 0.53
PLA2G2A P14555 7/20 0.45
HTT P42858 1/20 0.42
MAPK14 Q16539 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7014263 0.87 PLA2G1B (0.39) PLA2G1BMAPK14
SCHEMBL27478861 0.83 PLA2G1B (0.48) PLA2G1BPLA2G2A
SCHEMBL8327321 0.81 PLA2G1B (0.43) PLA2G1BPLA2G2AHTT
SCHEMBL7011352 0.81 FOLH1 (0.47) PLA2G1BMAPK14
SCHEMBL27478860 0.80 PLA2G1B (0.44) PLA2G1BPLA2G2A
SCHEMBL9080540 0.78 PLA2G1B (0.84) PLA2G1BPLA2G2A
SCHEMBL8345231 0.77 KDM4E (0.45) PLA2G1B
SCHEMBL7017215 0.74 PLA2G1B (0.83) PLA2G1BPLA2G2A
SCHEMBL1412911 0.73 HTR1A (0.59) HTT
SCHEMBL3952696 0.72 RXRA (0.49) PLA2G1BHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6645976-B1 Nonpancreatic secretory phospholipase (sPLA2) supressors such as 2-(3-Benzyl-8-hydroxy-2-ethylindolizin-1-yl)acetamide, administered to control release of fatty acid and prevent the arachidonic acid cascade; septic shock ELI LILLY AND COMPANY 2003-11-11 US disclosed
EP-0772596-B1 INDOLIZINE sPLA2 INHIBITORS LILLY CO ELI (US) 2003-10-01 EP disclosed
EP-0772596-A4 INDOLIZINE sPLA2 INHIBITORS LILLY CO ELI (US) 1999-01-13 EP disclosed
EP-0772596-A1 INDOLIZINE sPLA2 INHIBITORS ELI LILLY AND COMPANY (US) 1997-05-14 EP disclosed
WO-1996003383-A1 INDOLIZINE sPLA2 INHIBITORS ELI LILLY AND COMPANY (US) 1996-02-08 WO disclosed